A new clinical trial assessing the impacts of a digital exercise intervention on health outcomes and regular exercise engagement in individuals with prostate cancer has been announced. Sponsored by the Royal Marsden NHS Foundation Trust and King’s College London, the study introduces a supervised virtual group exercise initiative using innovative digital solutions for patient care.
What is the study about?
This clinical trial investigates the effectiveness of a digital exercise program for patients diagnosed with prostate cancer. The program includes virtual group sessions supervised by healthcare professionals and is designed to improve health outcomes and encourage consistent exercise practices among participants.
How does the intervention work?
The intervention leverages digital modalities to provide structured and supervised exercise sessions in a group setting. Patients will participate virtually, allowing them to connect with healthcare providers and peer groups without the need to travel. The supervised format ensures adherence to safety protocols and personalized guidance targeted to each participant’s needs, aligning with the current trends in digital health innovations.
Digital health interventions are increasingly utilized to address logistical and access challenges for patients. This approach combines convenience with evidence-based practices to ensure optimal clinical support.
Who qualifies for participation?
The study targets individuals who have been diagnosed with prostate cancer, specifically aiming at understanding the role exercise can play in managing the condition and improving patient quality of life. Recruitment has not yet begun, but eligibility criteria and detailed participation guidelines will likely be made available through official channels once the trial is active.
Frequently Asked Questions
-
1. When will the study begin recruiting?
Recruitment is currently listed as not started. Updates will be available on the ClinicalTrials.gov site and sponsor platforms.
-
2. How can interested individuals find out if they are eligible?
Eligibility criteria will be specified soon. These will include age, diagnosis stage, and other health-related factors.
-
3. Where will the virtual sessions be hosted?
Sessions will be hosted on secure online platforms, facilitating seamless interaction between participants and healthcare professionals.
Conclusion and next steps
This clinical trial represents a significant step in exploring digital health solutions for cancer management. By employing virtual supervised exercise programs, it addresses barriers such as access and convenience while emphasizing patient safety and tailored care. Stakeholders, including clinical, quality, and regulatory teams, should monitor developments in patient recruitment and program rollout.
Disclaimer
This article is intended for informational purposes only and does not constitute legal or medical advice. Professionals should consult regulatory guidelines or seek expert advice for compliance concerns.
Additional information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07243834?term=medical+device